Clicky

SHANGHAI JUNSHI BIO YC1(8SJ) News

Date Title
May 8 BioDlink Congratulates Junshi Biosciences on IND Approval of JS212, a Bispecific ADC Therapeutic Candidate
Apr 25 Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma